UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

The Evolving Mechanisms of Action of Glatiramer Acetate

Cold Spring Harbor perspectives in medicine, 2019-02, Vol.9 (2), p.a029249

2019

Link zum Volltext

Verfügbarkeit prüfen

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

The Journal of experimental medicine, 2013-12, Vol.210 (13), p.2921-2937

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

Nature communications, 2015-09, Vol.6 (1), p.8164-8164, Article 8164

2015

Link zum Volltext

Verfügbarkeit prüfen

Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors

Science translational medicine, 2016-11, Vol.8 (365), p.365ra158

2016

Link zum Volltext

Verfügbarkeit prüfen

Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity

Journal of neuroinflammation, 2014-02, Vol.11 (1), p.29-29, Article 29

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

The Journal of clinical investigation, 2006-04, Vol.116 (4), p.1037-1044

2006

Link zum Volltext

Verfügbarkeit prüfen

SLAT/Def6 Plays a Critical Role in the Development of Th17 Cell-Mediated Experimental Autoimmune Encephalomyelitis

The Journal of immunology (1950), 2009-12, Vol.183 (11), p.7259-7267

2009

Link zum Volltext

Verfügbarkeit prüfen

Statins in the treatment of central nervous system autoimmune disease

Journal of neuroimmunology, 2006-09, Vol.178 (1), p.140-148

2006

Link zum Volltext

Verfügbarkeit prüfen

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

Nature immunology, 2015-06, Vol.16 (6), p.618

2015

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate treatment negatively regulates type I interferon signaling

Neurology : neuroimmunology & neuroinflammation, 2015-12, Vol.2 (6), p.e179-e179

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor

Arthritis research & therapy, 2019-10, Vol.21 (1), p.216-216, Article 216

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE

Neurology : neuroimmunology & neuroinflammation, 2014-08, Vol.1 (2), p.e22-e22

2014

Link zum Volltext

Verfügbarkeit prüfen

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

Annals of neurology, 2010-09, Vol.68 (3), p.369-383

2010

Link zum Volltext

Verfügbarkeit prüfen

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

Nature medicine, 2007-08, Vol.13 (8), p.935-943

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation[S]

Molecular & cellular proteomics, 2019-03, Vol.18 (3), p.534-545

2019

Link zum Volltext

Verfügbarkeit prüfen

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

The Journal of experimental medicine, 2006-02, Vol.203 (2), p.401-412

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB027: In vivo delivery of novel CD89 fusion receptor to myeloid cells by mRNA activates anti-tumor immunity

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB027-LB027

2023

Link zum Volltext

Verfügbarkeit prüfen

Statins and their potential targets in multiple sclerosis therapy

Expert opinion on therapeutic targets, 2003-10, Vol.7 (5), p.613-622

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT131: Initial preclinical and clinical experience of autologous engineered monocytes in T cell lymphoma patients

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT131-CT131

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica

PloS one, 2010-11, Vol.5 (11), p.e15050-e15050

2010

Link zum Volltext

Verfügbarkeit prüfen

Statins as potential therapeutic agents in multiple sclerosis

Current neurology and neuroscience reports, 2004-05, Vol.4 (3), p.237-244

2004

Link zum Volltext

Verfügbarkeit prüfen

Bench to Bedside Tempering antigen-presenting cells in multiple sclerosis

Nature medicine, 2008-06, Vol.14 (6), p.614-615

2008

Link zum Volltext

Verfügbarkeit prüfen

Tempering antigen-presenting cells in multiple sclerosis

Nature medicine, 2008-06, Vol.14 (6), p.614-615

2008

Link zum Volltext

Verfügbarkeit prüfen

Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course

Immunogenetics (New York), 2003-11, Vol.55 (8), p.530-539

2003

Link zum Volltext

Verfügbarkeit prüfen

Isoforms of the class II transactivator protein

International immunology, 2002-08, Vol.14 (8), p.839-848

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(58)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Evolving Mechanisms of Action of Glatiramer Acetate

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors

Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

SLAT/Def6 Plays a Critical Role in the Development of Th17 Cell-Mediated Experimental Autoimmune Encephalomyelitis

Statins in the treatment of central nervous system autoimmune disease

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

Glatiramer acetate treatment negatively regulates type I interferon signaling

Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor

Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation[S]

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

Abstract LB027: In vivo delivery of novel CD89 fusion receptor to myeloid cells by mRNA activates anti-tumor immunity

Statins and their potential targets in multiple sclerosis therapy

Abstract CT131: Initial preclinical and clinical experience of autologous engineered monocytes in T cell lymphoma patients

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica

Statins as potential therapeutic agents in multiple sclerosis

Bench to Bedside Tempering antigen-presenting cells in multiple sclerosis

Tempering antigen-presenting cells in multiple sclerosis

Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course

Isoforms of the class II transactivator protein

Suchergebnisse filtern